Biohaven Therapeutics Ltd.

This study is testing whether an investigational drug called BHV-7000 can help reduce seizures in adults with focal epilepsy that hasn't been controlled by other medications. About 390 participants will be randomly assigned to receive either one of two doses of BHV-7000 or a plac…

This is an early-stage study to check if a new drug called BHV-1400 is safe for people with IgA nephropathy, a disease that damages the kidneys. The study will enroll 20 adults who have had the disease confirmed by a kidney biopsy. Researchers will closely monitor participants fo…

This study is testing whether an investigational drug called BHV-8000 can slow the progression of Parkinson's disease in people recently diagnosed. Researchers will compare the drug to a placebo in 550 adults to see if it helps maintain daily function and movement abilities over …

This is the first study in humans testing an experimental drug called BHV-1530 for adults with advanced or metastatic solid tumors that have stopped responding to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and check for early…

This study is testing whether a new injectable drug called taldefgrobep alfa can help adults with overweight or obesity lose weight. Researchers will compare the drug to a placebo (inactive shot) in 150 participants over 24 weeks to see how much body weight changes and check for …

This is the first-ever study in people of a new targeted cancer drug called BHV-1510. It aims to find a safe and effective dose for patients with advanced solid tumors that have stopped responding to standard treatments. The study will test the drug alone and combined with an exi…

This study is testing whether an experimental drug called BHV-7000 can help reduce seizures in adults with focal epilepsy that hasn't responded well to existing medications. About 390 participants will receive either the drug or a placebo (inactive substance) in addition to their…

This early study is testing whether a new drug called BHV-1300 is safe for people with Graves' disease, an autoimmune condition affecting the thyroid. Researchers will enroll 15 participants to monitor for side effects and check if the treatment affects specific markers of the di…